Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Filings indexed 1,441 across all filing types
Latest filing 2010-07-27 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
关于公司首次公开发行A股项目证券发行保荐工作报告
Audit Report / Information Classification · 95% confidence The document is titled "证券发行保荐工作报告" which translates to "Securities Issuance Sponsorship Work Report" related to 嘉事堂药业股份有限公司's initial public offering (IPO) of A shares. It details the internal project review process, due diligence, and regulatory compliance for the IPO. The content includes descriptions of the underwriting and sponsorship process, internal audit and review procedures, and responses to regulatory inquiries. This is a detailed report prepared by the sponsor (underwriter) for the IPO process, which is a type of audit or regulatory compliance report related to securities issuance, not a general annual or quarterly financial report. It is not an announcement or a brief summary but a comprehensive work report on the IPO sponsorship. Therefore, the most appropriate classification is Audit Report / Information (AR), as it is a standalone audit and regulatory compliance report related to the securities issuance process. Q1 2009
2010-07-27 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.